Related Experiment Videos
Risk factors for intraocular melanoma and occupational exposure
1Registre Genevois des Tumeurs, 55 Bvd de la Cluse, CH-1205 Genève, Switzerland.
The British Journal of Ophthalmology
|September 30, 1999
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Targeting EGFR and PI3K pathways in ovarian cancer.
British journal of cancer·2013
Identification of markers of prostate cancer progression using candidate gene expression.
British journal of cancer·2011
Circulating tumour markers can define patients with normal colons, benign polyps, and cancers.
British journal of cancer·2011
Molecular basis of chemosensitivity of platinum pre-treated ovarian cancer to chemotherapy.
British journal of cancer·2010
Measurement of cytotoxicity by ATP-based luminescence assay in primary cell cultures and cell lines.
Toxicology in vitro : an international journal published in association with BIBRA·2010
Evaluation of globe-preserving therapies in unilateral cT2/cT3 retinoblastoma: a multicentre study of 1566 eyes.
The British journal of ophthalmology·2026
Corneal radius-specific axial length/corneal radius ratio cut-offs for improved myopia detection in children: a population-based study.
The British journal of ophthalmology·2026
Aggressive retinopathy of prematurity: characteristics and risk factors for retreatment.
The British journal of ophthalmology·2026
Novel insights of minocycline as a neurovascular protective agent in retinitis pigmentosa.
The British journal of ophthalmology·2026
Astigmatism trends in adults of Hong Kong from 2015 to 2024: The Hong Kong Children Eye Study.
The British journal of ophthalmology·2026
Subchronic kretek smoke exposure induces myocardial p53 protein expression and associated inflammatory and fibrotic alterations in rats.
Journal of advanced pharmaceutical technology & research·2026
Correction: MCL-1 as a tumor microenvironment-linked survival node in cholangiocarcinoma.
Frontiers in oncology·2026